SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 177.82+1.0%Jan 2 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Lundberg who wrote (48)10/11/1996 10:43:00 PM
From: Michael H. Dragon   of 1686
 
Rick, thanks for keeping us all informed. Could you tell us if Avonex,
re-beta inteferon is still in trials for the treatment of hepatitis b
and c in cases where inteferon A is proving uneffective.Also does the
company feel as if avonex will one day be used for multiple indications
as Intron A has been or is Beta inteferons makeup that much different
from Alpha Inteferons.TIA, Mike D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News